Depression and glycemic control in hispanic primary care patients with diabetes

Gross, Raz; Olfson, Mark; Gameroff, Marc J.; Carasquillo, Olveen; Shea, Steven; Feder, Adriana; Lantigua, Rafael; Fuentes, Milton A.; Weissman, Myrna M.

doi:10.1111/j.1525-1497.2005.30003.x

Cited by 86 publications

(67 citation statements)

References 93 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These considerations may influence the attitudes of individuals with DM. Moreover, according to Gross et al [60], depressive symptoms can have a negative impact on important factors associated with self-care of patients with DM.…”

Section: Discussionmentioning

confidence: 99%

Association Between Major Depression And Type 2 Diabetes Mellitus: A Meta-Analysis And Meta-Regression Of Observational Studies

et al. 2016

View full text Add to dashboard Cite

The purpose of this review was to identify the prevalence of major depression in individuals with type 2 diabetes by means of a systematic review and meta-analysis. An electronic search was conducted for relevant studies published from January 1988 to December 2014. Cross-sectional and case-control studies in adults that evaluated the prevalence of major depression in individuals with type 2 Diabetes Mellitus were included. Meta-regression and sensitivity analyses were used to identify the sources of heterogeneity. Publication bias was assessed using a funnel plot and Egger's test. After the selection process, 18 cross-sectional and four case-control studies were included in the meta-analysis. In total, the occurrence of major depression was investigated in 5554 patients with diabetes mellitus type 2. The prevalence of major depression varied from 6.67% (95% CI: 4.54% -9.38%) to 55.38% (95% CI: 42.53% -67.73%), with an overall average of 21.13% (95% CI: 15.80% -27.66%). In American continent, the prevalence was 20.83% (95% CI: 13.12% -31.43%; I²=96.8%), and in Europe it was 18.00% (95% CI: 8.58% -33.91%; I²=93.8%). Both were lower than the rate in Asia, which was 23.49% (95% CI: 15.63% -33.74%; I²=90.8%). Meta-regression analysis found no evidence that the analyzed cofactors represented the cause of the heterogeneity seen. The approximately symmetrical distribution of the points in Funnel Plot suggests an absence of publication bias that was confirmed by Egger's test (p=0.2345). Based on the data collected, we can infer that the prevalence of major depression in individuals with type 2 diabetes was high, independent of geographic location.

show abstract

Section: Discussionmentioning

confidence: 99%

Association Between Major Depression And Type 2 Diabetes Mellitus: A Meta-Analysis And Meta-Regression Of Observational Studies

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Such rates give cause for concern in light of the significant impact that comorbid depression has been shown to have on glycemic control and diabetes complications (7,(11)(12)(13). Longitudinal studies are needed to evaluate the effectiveness of depression treatment in community samples.…”

Section: Satisfaction With Depression Treatmentmentioning

confidence: 99%

Depression Treatment and Satisfaction in a Multicultural Sample of Type 1 and Type 2 Diabetic Patients

et al. 2006

View full text Add to dashboard Cite

OBJECTIVE—To assess rates of depressive symptoms, depression treatment, and satisfaction in a multicultural sample of individuals with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS—This study was conducted with a cross-sectional community-based survey design. RESULTS—The sample (n = 221) was predominantly female (60.3%), had type 2 diabetes (75%), and was middle class with a mean (±SD) age of 54 ± 12 years. A total of 53% were white. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CESD) (mean 16.4 ± 11.3). Using conservative thresholds (CESD score ≥22), 25.3% of participants reported clinically significant depression. Rates of depression did not differ by ethnic group or diabetes type. The majority (76%) of depressed participants reported treatment (52% antidepressants, 63% mental health providers, 19% alternative healers, and 15% herbal remedies). African Americans were less likely to report any depression treatment, to receive antidepressant medications, or receive treatment from a mental health professional compared with whites. Participants with high depressive symptoms reported general satisfaction with depression treatment experiences. CONCLUSIONS—High rates of depressive symptoms were observed across ethnic groups, yet significant differences in use of depression treatment existed across ethnic groups. Those seeking depression treatment reported satisfaction with a variety of depression treatment modalities. Increased depression screening and treatment may be beneficial for ethnically diverse patients with type 1 and type 2 diabetes.

show abstract

“…Previous research about Hispanics with type 2 diabetes in the United Sates found that correlates to depression include age, 8 education, 8,23 financial stress, 23 poorer self-rated health, 24 diabetes-related functional impact, 23 understanding and knowledge of diabetes, 24 lifestyle behaviors, 25 and poor glycemic control. 26 Research examining depression and diabetes in patients along the United States Mexico border is warranted. High diabetes prevalence rates and related comorbidities in the border region not only affect patients' quality of life but also result in high economic costs for both the US and Mexico health care systems and communities.…”

mentioning

confidence: 99%